Recursion Pharmaceuticals, Inc. (RXRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.29
Day's range
$3.54

Recursion Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 43.19 M $132.60 M   11.13% 9.65%
ARK INVESTMENT MANAGEMENT LLC 05/12/2026 40.21 M $123.45 M   7.76% 8.99%
STATE STREET CORP 05/15/2026 28.49 M $87.47 M   12.46% 6.37%
BAILLIE GIFFORD & CO 05/08/2026 23.68 M $72.68 M   -0.42% 5.29%
05/08/2026 22.76 M $69.87 M   100.00% 5.09%
05/15/2026 22.24 M $68.29 M   100.00% 4.97%
SOFTBANK GROUP CORP. 05/15/2026 13.64 M $41.86 M   0.00% 3.05%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 12.28 M $37.69 M   12.26% 2.74%
MIC CAPITAL MANAGEMENT UK LLP 05/13/2026 9.64 M $29.61 M   0.00% 2.16%
GOLDMAN SACHS GROUP INC 05/15/2026 6.07 M $18.62 M   175.53% 1.36%
DATA COLLECTIVE IV GP, LLC 05/15/2026 5.94 M $18.24 M   0.00% 1.33%
EXOR CAPITAL LLP 05/14/2026 5.88 M $18.06 M   19.28% 1.31%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/30/2026 5.42 M $16.64 M   -12.89% 1.21%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2026 5.42 M $16.58 M   -12.89% 1.21%
UBS GROUP AG 05/05/2026 5.10 M $15.66 M   38.17% 1.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 4.23 M $12.97 M   -3.89% 0.94%
TWO SIGMA INVESTMENTS, LP 05/15/2026 4.07 M $12.48 M   32.23% 0.91%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 4.02 M $12.35 M   -1.27% 0.90%
NORTHERN TRUST CORP 05/14/2026 3.97 M $12.18 M   15.36% 0.89%
DCVC OPPORTUNITY FUND II GP, LLC 05/15/2026 3.95 M $12.13 M   0.00% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 3.81 M $11.69 M   -4.65% 0.85%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 3.51 M $10.79 M   100.00% 0.79%
MARSHALL WACE, LLP 05/15/2026 2.88 M $8.83 M   1,169.56% 0.64%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 2.63 M $8.08 M   19.23% 0.59%
MILLENNIUM MANAGEMENT LLC 05/15/2026 2.61 M $8.02 M   74.64% 0.58%
FIRST TRUST ADVISORS LP 05/13/2026 2.61 M $8.01 M   15.18% 0.58%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 05/11/2026 2.56 M $7.85 M   6.38% 0.57%
BANK OF AMERICA CORP /DE/ 05/18/2026 2.50 M $7.67 M   18.20% 0.56%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 2.40 M $7.37 M   100.00% 0.54%
MORGAN STANLEY 05/15/2026 2.19 M $6.71 M   -61.37% 0.49%
CAPITAL FUND MANAGEMENT S.A. 05/14/2026 1.91 M $5.86 M   7.34% 0.43%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 1.53 M $4.69 M   -37.83% 0.34%
BANK OF NEW YORK MELLON CORP 05/05/2026 1.46 M $4.49 M   29.26% 0.33%
JPMORGAN CHASE & CO 05/13/2026 1.33 M $3.78 M   4.04% 0.30%
MAN GROUP PLC 05/15/2026 1.20 M $3.68 M   4,190.28% 0.27%
NUVEEN, LLC 04/30/2026 1.16 M $3.58 M   7.34% 0.26%
CITADEL ADVISORS LLC 05/15/2026 1.01 M $3.10 M   -48.97% 0.23%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 05/15/2026 941.90 K $2.89 M   0.00% 0.21%
MITSUBISHI UFJ TRUST & BANKING CORP 05/12/2026 908.46 K $2.79 M   100.00% 0.20%
GROUP ONE TRADING, L.P. 05/13/2026 901.11 K $2.77 M   100.00% 0.20%
RAFFERTY ASSET MANAGEMENT, LLC 05/15/2026 890.60 K $2.73 M   -8.07% 0.20%
JUMP FINANCIAL, LLC 05/14/2026 889.93 K $2.73 M   34.51% 0.20%
SWISS NATIONAL BANK 05/07/2026 877.00 K $2.69 M   21.75% 0.20%
CITADEL ADVISORS LLC 05/15/2026 798.90 K $2.45 M   -59.36% 0.18%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2026 790.97 K $2.43 M   -1.01% 0.18%
STIFEL FINANCIAL CORP 05/12/2026 776.93 K $2.39 M   31.65% 0.17%
FMR LLC 05/15/2026 736.65 K $2.26 M   -77.28% 0.16%
VESTMARK ADVISORY SOLUTIONS, INC. 05/15/2026 726.99 K $2.23 M   20.21% 0.16%
INVESCO LTD. 05/12/2026 691.15 K $2.12 M   31.36% 0.15%
JANE STREET GROUP, LLC 05/12/2026 682.10 K $2.09 M   -2.74% 0.15%

Recursion Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 410 institutional investors and hedge funds held shares of Recursion Pharmaceuticals Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 43.19 M

ARK Investment Management LLC: 40.21 M

STATE STREET CORP: 28.49 M

BAILLIE GIFFORD & CO: 23.68 M

SOFTBANK GROUP CORP.: 13.64 M

GEODE CAPITAL MANAGEMENT, LLC: 12.28 M

75.13% of Recursion Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 385.48 M shares in the last 24 months. This purchase volume represents approximately $1.35 B in transactions.